
Refinitiv Eikon
View the recommended PC requirements for Refinitiv Eikon. Ensure your computer and network meet the requirements to install and run Refinitiv Eikon. Compare features with the desktop …
Eikon Therapeutics
Eikon has a growing therapeutic pipeline with the ability to deliver new medicines to address serious illnesses. At Eikon we know better insights will lead to better medicines.
Strong's Greek: 1504. εἰκών (eikón) -- Image, likeness, …
1504 eikṓn (from 1503 /eíkō, "be like") – properly, "mirror-like representation," referring to what is very close in resemblance (like a "high-definition" projection, as defined by the context). Image …
Eikon remains in megaround mode with $350M series D
Feb 26, 2025 · California-based Eikon emerged publicly in 2021 with a stated goal to apply live-cell super-resolution microscopy to drug discovery.
Eikon Raises $350M for Cancer Drug Pipeline Led by Melanoma …
Feb 26, 2025 · Eikon Therapeutics’ lead drug candidate is designed to activate toll-like receptors 7 and 8, sparking an immune response that fights cancer. Beyond this TLR7/8 agonist, the …
Eikon raises $351M in one of the year’s largest biotech venture …
Feb 26, 2025 · Eikon was formed around a Nobel Prize-winning technology that helps scientists look at how proteins move inside of cells. The company debuted publicly in 2021 with Roger …
Eikon pulls in $351M as lead drug begins Phase III journey
Feb 26, 2025 · Founded back in 2019, Eikon has since raised over $1.1 billion as it looks to build a pipeline leveraging Nobel Prize-winning super-resolution microscopy to visualise and …
Eikon Therapeutics Talks Platforms but Bets Big on Acquired …
Eikon Therapeutics has raised over $1B and claims to have a revolutionary drug discovery platform, but its clinical pipeline remains dominated by acquired oncology assets. This report …
About Us – Eikon Therapeutics
Our collaborative approach to drug discovery enables researchers and engineers to invent solutions to extremely difficult problems. Eikon is a singular company, dedicated to creating …
Eikon becomes a pivotal-stage biotech | ApexOnco - Clinical Trials …
Dec 2, 2024 · Armed with last year's $106m series C financing, and after a series B brought in a massive $518m in 2022, Eikon Therapeutics is now a pivotal-stage biotech company.